Status:
COMPLETED
Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder
Lead Sponsor:
Cephalon
Conditions:
General Anxiety Disorder
Eligibility:
All Genders
18-64 years
Phase:
PHASE3
Brief Summary
To assess the long-term safety and tolerability of tiagabine treatment in patients with generalized anxiety disorder (GAD).
Eligibility Criteria
Inclusion
- Not available at time of registration
Exclusion
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00233675
Start Date
August 1 2003
Last Update
April 12 2023
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Pivotal Research Center
Mesa, Arizona, United States, 85210
2
Southwestern Research
Beverly Hills, California, United States, 90210
3
Pharmacology Research Institut
Newport Beach, California, United States, 92660
4
Pharmacology Research Institut
Northridge, California, United States, 91324